Utility of Brain Natriuretic Peptide (BNP) in Patients With Type IV Cardio-renal Syndrome Admitted to the Intensive Care Unit (ICU)

Hallym University Medical Center83 enrolled

Overview

Admission BNP was a useful marker for diagnosing and predicting type IV cardio-renal syndrome type IV in patients with chronic kidney disease admitted to the ICU for acute heart failure in a retrospective study. Therefore, we aim to prospectively investigate the utility of serum BNP in evaluating the treatment adequacy and predicting future cardiac events in patients with type IV CRS.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Chronic Kidney Disease Acute Heart Failure

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Adult patients aged \> 18 years, Patients with chronic kidney disease (Serum Cr \> 2.0, Documented medical history of chronic kidney disease Exclusion Criteria: * Cardiopulmonary resuscitation, Do-not-resuscitate state, Acute kidney injury, ICU stay \< 1 day

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.